Design Therapeutics, Inc.
(DSGN - NASDAQ)
12,81 USD
📋 Profilo Aziendale

Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions.

|